Monday, May 11, 2026
Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Environment. CoreCivic’s near-term performance will reflect the ultimate moves ICE makes. We continue to believe the services provided by CoreCivic are the best value for the Federal government to manage the immigration crisis. We believe the new leadership at DHS is likely to continue to pursue the use of private operators going forward.
Clinical Solutions Pharmacy Acquisition. As mentioned in our initial First Look at 1Q26, subsequent to the quarter’s end, CoreCivic acquired Clinical Solutions Pharmacy (“CSP”), one of the largest providers of mail order pharmacy services to correctional facilities in the United States. We expect the acquisition of CSP to diversify CoreCivic’s cash flows in a complementary business and a growing market. We believe there are additional opportunities for CoreCivic to expand this business further.
Get the Full Report
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
